Evidence map›Paper›PMID 36648844›Full record

ArticleClinics and practice2022

Effects of Mediterranean Diet, DASH Diet, and Plant-Based Diet on Outcomes among End Stage Kidney Disease Patients: A Systematic Review and Meta-Analysis.

Mariam Charkviani, Charat Thongprayoon, Supawit Tangpanithandee, Pajaree Krisanapan, Jing Miao, Michael A Mao, Wisit Cheungpasitporn

Open access · goldAbstract read
In one paragraph

Article in Clinics and practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Mariam CharkvianiDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0002-8854-8796
Charat ThongprayoonDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA.
Supawit TangpanithandeeDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0001-6103-2338
Pajaree KrisanapanDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0002-2888-881X
Jing MiaoDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA.
Michael A MaoDepartment of Nephrology and Hypertension, Mayo Clinic, Jacksonville, FL 32224, USA.ORCID 0000-0003-1814-7003
Wisit CheungpasitpornDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0001-9954-9711
Mayo Clinic · USMayo Clinic in Florida · USThammasat University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Mediterranean, Dietary Approach to Stop Hypertension (DASH), and plant-based diets may provide cardiovascular benefit to the general population. However, data on their effect on end stage kidney disease (ESKD) patients are limited. This systematic review aims to assess the impact of Mediterranean, DASH, and plant-based diets on outcomes among ESKD patients.

methodsA literature review was conducted in EMBASE, MEDLINE, and Cochrane databases from inception through September 2022 to identify studies that assess the clinical outcomes of Mediterranean, DASH, or plant-based diets on ESKD patients on hemodialysis (HD) or peritoneal dialysis (PD). Effect estimates from the individual studies were derived utilizing the random-effect, generic inverse variance approach of DerSimonian and Laird.

resultsSeven studies with 9400 ESKD patients (8395 HD and 1005 PD) met the eligibility criteria and were included in the data analysis. Pooled odds ratios (ORs) of mortality for ESKD patients who adhered to the Mediterranean versus plant-based diet were 0.49 (95% CI: 0.07-3.54; two studies, I

conclusionsWhile our systematic review demonstrated no significant associations of Mediterranean, DASH, and plant-based diets with reduced all-cause mortality or cardiovascular mortality, there was also no evidence that suggested harmful effects of these diets to ESKD patients.

Indexed as

DASHend stage kidney diseasehemodialysisMediterranean dietperitoneal dialysisplant-based diet

Identifiers

PMID36648844
PMCPMC9844348
OpenAlexW4313414641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.